The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease
Authors:
- 1 October 2011
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 236 (10) , 1116-1121
Abstract
The fatty acid translocase (FAT)/CD36 belongs to the class B scavenger receptor family. In addition to the known functions of CD36 in the uptake of oxidized low-density lipoprotein by macrophages and uptake of fatty acids by adipose tissues, skeletal muscle and heart, emerging evidence has pointed to an equally important function of CD36 in the uptake of fatty acids in the liver and the pathogenesis of fatty liver disease. Recent reports have also suggested CD36 as a shared transcriptional target of several ligand-sensing and lipogenic transcriptional factors, such as the aryl hydrocarbon receptor, and several nuclear hormone receptors, such as pregnane X receptor, liver X receptor and peroxisome proliferator activated receptor γ. Non-alcoholic fatty liver disease is common and medically significant, because it is closely related to metabolic syndrome and has a potential to progress into the more harmful non-alcoholic steatohepatitis. It is hoped that CD36 and their transcriptional regulators can represent novel therapeutic targets for the prevention and management of fatty liver disease.Keywords
This publication has 63 references indexed in Scilit:
- CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCsJournal of Clinical Investigation, 2010
- FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic SteatosisGastroenterology, 2010
- Role of Scavenger Receptor A and CD36 in Diet-Induced Nonalcoholic Steatohepatitis in Hyperlipidemic MiceGastroenterology, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves HyperglycemiaJournal of Biological Chemistry, 2008
- NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on AdipogenesisMolecular and Cellular Biology, 2007
- The Aryl hydrocarbon receptor is activated by modified low-density lipoproteinProceedings of the National Academy of Sciences, 2007
- PPARγ activation induces CD36 expression and stimulates foam cell like changes in rVSMCsProstaglandins & Other Lipid Mediators, 2006
- PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activationJournal of Lipid Research, 2003